Opus Genetics officer proposes $117K share sale

The notice states the proposed trades are not discretionary and are required to cover tax obligations.

Rhea-AI Filing Summary

Opus Genetics, Inc. (IRD) officer Benjamin R. Yerxa gave notice of a proposed sale of 33,189 common shares, with an aggregate market value of $117,364.67 and an approximate sale date of October 23, 2026. Raymond James & Associates, Inc. is identified as the broker. The notice lists a common-stock RSU share vest from the issuer on October 22, 2026, and states the trades are not discretionary because they are required to cover tax obligations. It also reports that Yerxa sold 7,429 common shares for $22,064.00 on July 23, 2026.

Key Figures

Proposed common shares for sale: 33,189 shares Aggregate market value: $117,364.67 Shares outstanding: 83,195,823 shares +2 more

5 metrics

Proposed common shares for sale 33,189 shares Approximate sale date October 23, 2026

Aggregate market value $117,364.67 Proposed sale

Shares outstanding 83,195,823 shares Issuer figure reported with the proposed-sale information

Prior common shares sold 7,429 shares July 23, 2026

Gross proceeds from prior sale $22,064.00 Sale on July 23, 2026

Key Terms

RSU SHARE VEST, Rule 144, attorney-in-fact

3 terms

RSU SHARE VEST financial

"common stock acquired through an RSU share vest"

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

attorney-in-fact technical

"as attorney-in-fact for Benjamin R Yerxa"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Opus Genetics (IRD) shares did Benjamin R. Yerxa plan to sell?

Benjamin R. Yerxa reported a proposed sale of 33,189 common shares, with an aggregate market value of $117,364.67 and an approximate sale date of October 23, 2026. Raymond James & Associates, Inc. is identified as the broker.

Why is Benjamin R. Yerxa proposing to sell Opus Genetics (IRD) shares?

The notice states the trades are not discretionary because they are required to cover tax obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/23/2026 - 04:58 PM EDT Accepted by SEC EDGAR 10/23/2026 - 04:57 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001145910
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Opus Genetics, Inc.
SEC File Number	001-34079
Address of Issuer	8 DAVIS DRIVE SUITE 220 DURHAM NORTH CAROLINA 27713
Phone	(984) 884-6030
Name of Person for Whose Account the Securities are To Be Sold	YERXA BENJAMIN R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg, FL 33716	33189	117364.67	83195823	10/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	10/22/2026	RSU SHARE VEST	ISSUER			108200	10/23/2026	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BENJAMIN YERXA 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713	Common	07/23/2026	7429	22064.00

144: Remarks and Signature

Remarks	TRADES ARE NOT DISCRETIONARY AS THEY ARE REQUIRED TO COVER TAX OBLIGATIONS
Date of Notice	10/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Benjamin R Yerxa
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)